drugset / Trial / NCT07835555

Smoking Cessation Medication And Rewards Using a Teamlet to Treat Tobacco Use Disorder (SMARTTT 2.0) Among Persons With HIV: A Multi-site Hybrid Type 2 Effectiveness-implementation Trial

NCT07835555 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

Cigarette smoking is an important cause of illness and death among persons with HIV (PWH). This project will study the impact of adding contingency management (use of financial rewards) to receiving medications and counseling on promoting smoking abstinence and other health outcomes among PWH. As treatments will be provided by clinical pharmacists and other team members in HIV clinics, factors relevant for implementing this model to inform real-world practice will also be evaluated.

Timeline

Start
2027-09-30
Primary completion
2030-09-30
Completion
2031-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule — —
Subject Nicotine Unknown — —
Subject Varenicline Small molecule — —